Clinical Trial Update: A Study Evaluating the Long-term Safety of VX-445 Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the long-term safety of VX-445 combination therapy in cystic fibrosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-445

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-06